HEADER TRANSFERASE 05-JAN-19 6J3P
TITLE CRYSTAL STRUCTURE OF THE HUMAN GCN5 BROMODOMAIN IN COMPLEX WITH
TITLE 2 COMPOUND (R,R)-36N
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HISTONE ACETYLTRANSFERASE KAT2A;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: GENERAL CONTROL OF AMINO ACID SYNTHESIS PROTEIN 5-LIKE 2,
COMPND 5 HISTONE ACETYLTRANSFERASE GCN5,HGCN5,HISTONE SUCCINYLTRANSFERASE
COMPND 6 KAT2A,LYSINE ACETYLTRANSFERASE 2A,STAF97;
COMPND 7 EC: 2.3.1.48,2.3.1.-;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: KAT2A, GCN5, GCN5L2;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS CRYSTAL STRUCTURE OF THE HUMAN GCN5 BROMODOMAIN IN COMPLEX WITH
KEYWDS 2 COMPOUND (R, R)-36N, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR L.Y.HUANG,H.LI,L.NIU,C.Y.WU,Y.M.YU,L.L.LI,S.Y.YANG
REVDAT 3 22-NOV-23 6J3P 1 REMARK
REVDAT 2 22-MAY-19 6J3P 1 JRNL
REVDAT 1 01-MAY-19 6J3P 0
JRNL AUTH L.HUANG,H.LI,L.LI,L.NIU,R.SEUPEL,C.WU,W.CHENG,C.CHEN,B.DING,
JRNL AUTH 2 P.E.BRENNAN,S.YANG
JRNL TITL DISCOVERY OF PYRROLO[3,2- D]PYRIMIDIN-4-ONE DERIVATIVES AS A
JRNL TITL 2 NEW CLASS OF POTENT AND CELL-ACTIVE INHIBITORS OF
JRNL TITL 3 P300/CBP-ASSOCIATED FACTOR BROMODOMAIN.
JRNL REF J.MED.CHEM. V. 62 4526 2019
JRNL REFN ISSN 0022-2623
JRNL PMID 30998845
JRNL DOI 10.1021/ACS.JMEDCHEM.9B00096
REMARK 2
REMARK 2 RESOLUTION. 1.60 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX (1.14RC3_3199)
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.11
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6
REMARK 3 NUMBER OF REFLECTIONS : 34284
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.156
REMARK 3 R VALUE (WORKING SET) : 0.155
REMARK 3 FREE R VALUE : 0.181
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.810
REMARK 3 FREE R VALUE TEST SET COUNT : 1991
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 39.1258 - 3.8508 1.00 2479 154 0.1751 0.1981
REMARK 3 2 3.8508 - 3.0568 1.00 2367 144 0.1573 0.1773
REMARK 3 3 3.0568 - 2.6705 1.00 2342 153 0.1548 0.1611
REMARK 3 4 2.6705 - 2.4264 1.00 2331 138 0.1565 0.2030
REMARK 3 5 2.4264 - 2.2525 1.00 2306 144 0.1397 0.1855
REMARK 3 6 2.2525 - 2.1197 1.00 2313 139 0.1423 0.1675
REMARK 3 7 2.1197 - 2.0136 1.00 2286 146 0.1489 0.1608
REMARK 3 8 2.0136 - 1.9259 1.00 2307 144 0.1452 0.1737
REMARK 3 9 1.9259 - 1.8518 1.00 2295 138 0.1526 0.1921
REMARK 3 10 1.8518 - 1.7879 1.00 2291 139 0.1491 0.1782
REMARK 3 11 1.7879 - 1.7320 1.00 2273 141 0.1429 0.1830
REMARK 3 12 1.7320 - 1.6825 1.00 2254 145 0.1457 0.1808
REMARK 3 13 1.6825 - 1.6382 1.00 2295 140 0.1453 0.1811
REMARK 3 14 1.6382 - 1.5982 0.95 2154 126 0.1598 0.1994
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : NULL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.120
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.230
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.017 1900
REMARK 3 ANGLE : 1.468 2579
REMARK 3 CHIRALITY : 0.080 264
REMARK 3 PLANARITY : 0.011 323
REMARK 3 DIHEDRAL : 15.770 1139
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 6J3P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 22-JAN-19.
REMARK 100 THE DEPOSITION ID IS D_1300010408.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 30-NOV-18
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SSRF
REMARK 200 BEAMLINE : BL18U1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97930
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34345
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.598
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 200 DATA REDUNDANCY : 12.80
REMARK 200 R MERGE (I) : 0.09900
REMARK 200 R SYM (I) : 0.09900
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 30.1670
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 0.46300
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 5MLJ
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 37.98
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM ACETATE, 0.1 M TRIS PH
REMARK 280 8.5, 25% W/V POLYETHYLENE GLYCOL 3,350, VAPOR DIFFUSION, SITTING
REMARK 280 DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.78600
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.11100
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.54600
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.11100
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.78600
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.54600
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 703
REMARK 465 HIS A 704
REMARK 465 HIS A 705
REMARK 465 HIS A 706
REMARK 465 HIS A 707
REMARK 465 HIS A 708
REMARK 465 HIS A 709
REMARK 465 SER A 710
REMARK 465 SER A 711
REMARK 465 GLY A 712
REMARK 465 VAL A 713
REMARK 465 ASP A 714
REMARK 465 LEU A 715
REMARK 465 GLY A 716
REMARK 465 THR A 717
REMARK 465 GLU A 718
REMARK 465 ASN A 719
REMARK 465 LEU A 720
REMARK 465 TYR A 721
REMARK 465 PHE A 722
REMARK 465 GLN A 723
REMARK 465 SER A 724
REMARK 465 MET A 725
REMARK 465 GLU A 726
REMARK 465 LEU A 727
REMARK 465 LYS A 728
REMARK 465 LYS A 837
REMARK 465 MET B 703
REMARK 465 HIS B 704
REMARK 465 HIS B 705
REMARK 465 HIS B 706
REMARK 465 HIS B 707
REMARK 465 HIS B 708
REMARK 465 HIS B 709
REMARK 465 SER B 710
REMARK 465 SER B 711
REMARK 465 GLY B 712
REMARK 465 VAL B 713
REMARK 465 ASP B 714
REMARK 465 LEU B 715
REMARK 465 GLY B 716
REMARK 465 THR B 717
REMARK 465 GLU B 718
REMARK 465 ASN B 719
REMARK 465 LEU B 720
REMARK 465 TYR B 721
REMARK 465 PHE B 722
REMARK 465 GLN B 723
REMARK 465 SER B 724
REMARK 465 MET B 725
REMARK 465 GLU B 726
REMARK 465 LEU B 727
REMARK 465 LYS B 728
REMARK 465 ASP B 729
REMARK 465 PRO B 730
REMARK 465 LEU B 834
REMARK 465 ILE B 835
REMARK 465 ASP B 836
REMARK 465 LYS B 837
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 OE1 GLU B 813 NH1 ARG B 816 2.09
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 ARG A 781 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES
REMARK 500 ARG B 816 NE - CZ - NH1 ANGL. DEV. = -3.2 DEGREES
REMARK 500 ARG B 816 NE - CZ - NH2 ANGL. DEV. = 4.3 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA B 762 82.61 -160.42
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue B8O A 900
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue B8O B 900
DBREF 6J3P A 726 837 UNP Q92830 KAT2A_HUMAN 726 837
DBREF 6J3P B 726 837 UNP Q92830 KAT2A_HUMAN 726 837
SEQADV 6J3P MET A 703 UNP Q92830 INITIATING METHIONINE
SEQADV 6J3P HIS A 704 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P HIS A 705 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P HIS A 706 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P HIS A 707 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P HIS A 708 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P HIS A 709 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P SER A 710 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P SER A 711 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P GLY A 712 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P VAL A 713 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P ASP A 714 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P LEU A 715 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P GLY A 716 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P THR A 717 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P GLU A 718 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P ASN A 719 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P LEU A 720 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P TYR A 721 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P PHE A 722 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P GLN A 723 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P SER A 724 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P MET A 725 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P MET B 703 UNP Q92830 INITIATING METHIONINE
SEQADV 6J3P HIS B 704 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P HIS B 705 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P HIS B 706 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P HIS B 707 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P HIS B 708 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P HIS B 709 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P SER B 710 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P SER B 711 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P GLY B 712 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P VAL B 713 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P ASP B 714 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P LEU B 715 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P GLY B 716 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P THR B 717 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P GLU B 718 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P ASN B 719 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P LEU B 720 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P TYR B 721 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P PHE B 722 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P GLN B 723 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P SER B 724 UNP Q92830 EXPRESSION TAG
SEQADV 6J3P MET B 725 UNP Q92830 EXPRESSION TAG
SEQRES 1 A 135 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU
SEQRES 2 A 135 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLU LEU LYS
SEQRES 3 A 135 ASP PRO ASP GLN LEU TYR THR THR LEU LYS ASN LEU LEU
SEQRES 4 A 135 ALA GLN ILE LYS SER HIS PRO SER ALA TRP PRO PHE MET
SEQRES 5 A 135 GLU PRO VAL LYS LYS SER GLU ALA PRO ASP TYR TYR GLU
SEQRES 6 A 135 VAL ILE ARG PHE PRO ILE ASP LEU LYS THR MET THR GLU
SEQRES 7 A 135 ARG LEU ARG SER ARG TYR TYR VAL THR ARG LYS LEU PHE
SEQRES 8 A 135 VAL ALA ASP LEU GLN ARG VAL ILE ALA ASN CYS ARG GLU
SEQRES 9 A 135 TYR ASN PRO PRO ASP SER GLU TYR CYS ARG CYS ALA SER
SEQRES 10 A 135 ALA LEU GLU LYS PHE PHE TYR PHE LYS LEU LYS GLU GLY
SEQRES 11 A 135 GLY LEU ILE ASP LYS
SEQRES 1 B 135 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU
SEQRES 2 B 135 GLY THR GLU ASN LEU TYR PHE GLN SER MET GLU LEU LYS
SEQRES 3 B 135 ASP PRO ASP GLN LEU TYR THR THR LEU LYS ASN LEU LEU
SEQRES 4 B 135 ALA GLN ILE LYS SER HIS PRO SER ALA TRP PRO PHE MET
SEQRES 5 B 135 GLU PRO VAL LYS LYS SER GLU ALA PRO ASP TYR TYR GLU
SEQRES 6 B 135 VAL ILE ARG PHE PRO ILE ASP LEU LYS THR MET THR GLU
SEQRES 7 B 135 ARG LEU ARG SER ARG TYR TYR VAL THR ARG LYS LEU PHE
SEQRES 8 B 135 VAL ALA ASP LEU GLN ARG VAL ILE ALA ASN CYS ARG GLU
SEQRES 9 B 135 TYR ASN PRO PRO ASP SER GLU TYR CYS ARG CYS ALA SER
SEQRES 10 B 135 ALA LEU GLU LYS PHE PHE TYR PHE LYS LEU LYS GLU GLY
SEQRES 11 B 135 GLY LEU ILE ASP LYS
HET B8O A 900 29
HET B8O B 900 29
HETNAM B8O 2-{[(3R,5R)-5-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-1-
HETNAM 2 B8O METHYLPIPERIDIN-3-YL]AMINO}-3-METHYL-3,5-DIHYDRO-4H-
HETNAM 3 B8O PYRROLO[3,2-D]PYRIMIDIN-4-ONE
FORMUL 3 B8O 2(C21 H25 N5 O3)
FORMUL 5 HOH *286(H2 O)
HELIX 1 AA1 ASP A 729 HIS A 747 1 19
HELIX 2 AA2 PRO A 748 MET A 754 5 7
HELIX 3 AA3 ASP A 764 ILE A 769 1 6
HELIX 4 AA4 ASP A 774 SER A 784 1 11
HELIX 5 AA5 THR A 789 ASN A 808 1 20
HELIX 6 AA6 SER A 812 GLY A 832 1 21
HELIX 7 AA7 GLN B 732 SER B 746 1 15
HELIX 8 AA8 ALA B 750 MET B 754 5 5
HELIX 9 AA9 ASP B 764 ILE B 769 1 6
HELIX 10 AB1 ASP B 774 SER B 784 1 11
HELIX 11 AB2 THR B 789 ASN B 808 1 20
HELIX 12 AB3 SER B 812 GLY B 832 1 21
SITE 1 AC1 9 TRP A 751 PRO A 752 PRO A 756 VAL A 757
SITE 2 AC1 9 GLU A 761 ASN A 808 TYR A 814 HOH A1013
SITE 3 AC1 9 HOH A1020
SITE 1 AC2 10 TRP B 751 PRO B 752 PRO B 756 VAL B 757
SITE 2 AC2 10 GLU B 761 TYR B 807 ASN B 808 TYR B 814
SITE 3 AC2 10 HOH B1015 HOH B1051
CRYST1 45.572 73.092 76.222 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.021943 0.000000 0.000000 0.00000
SCALE2 0.000000 0.013681 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013120 0.00000